| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-21,314.4557 | -15,411 | -10,099 | -11,609.8601 | -8,519.2604 |
|
Research and Development Expenses
|
-17,293.3656 | -13,314 | -15,443 | -13,113.0182 | -11,844.0745 |
| Depreciation, Amortization and Depletion
|
-309.1911 | -- | -309.1911 | -298.4102 | -300.8604 |
|
Operating Income/Expenses
|
-38,472.4743 | -28,725 | -25,542 | -25,021.2886 | -20,664.1953 |
|
Total Operating Profit/Loss
|
-38,472.4743 | -28,725 | -25,542 | -25,021.2886 | -20,664.1953 |
| Total Net Finance Income/Expense
|
306.0180 | 386 | 975 | 981.8658 | 405.2405 |
| Net Investment Income
|
237.6690 | 47 | 1,868 | 3,561.6702 | 1,262.5390 |
|
Other Income/Expense, Non-Operating
|
-388 | -388 | -- | -- | -- |
|
Non-Operating Income/Expenses, Total
|
155.6870 | 45 | 2,843 | 4,543.5361 | 1,667.7795 |
|
Pretax Income
|
-38,316.7873 | -28,680 | -22,699 | -20,477.7525 | -18,996.4158 |
|
Provision for Income Tax
|
-116.2967 | -79 | -95 | -71.8258 | -64.4701 |
|
Net Income from Continuing Operations
|
-38,433.0840 | -28,759 | -22,794 | -20,549.5783 | -19,060.8858 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-38,433.0840 | -28,759 | -22,794 | -20,549.5783 | -19,060.8858 |
|
Net Income after Non-Controlling/Minority Interests
|
-38,433.0840 | -28,759 | -22,794 | -20,549.5783 | -19,060.8858 |
|
Net Income Available to Common Stockholders
|
-38,433.0840 | -28,759 | -22,794 | -20,549.5783 | -19,060.8858 |
|
Diluted Net Income Available to Common Stockholders
|
-38,433.0840 | -28,759 | -22,794 | -20,549.5783 | -19,060.8858 |
| Basic EPS
|
-0.35 | -0.30 | -0.30 | -0.30 | -0.33 |
| Diluted EPS
|
-0.35 | -0.30 | -0.30 | -0.30 | -0.33 |
|
Basic Weighted Average Shares Outstanding
|
109,959.0100 | 95,857.1470 | 76,482.9140 | 67,624.0360 | 58,029.7450 |
|
Diluted Weighted Average Shares Outstanding
|
109,959.0100 | 95,857.1470 | 76,482.9140 | 67,624.0360 | 58,029.7450 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-38,622.8053 | -29,066 | -23,674 | -21,459.6184 | -19,401.6563 |
|
EBITDA
|
-38,558.8053 | -28,996 | -23,587 | -21,161.2082 | -19,100.7959 |
|
Normalized EBITDA
|
-33,061.9289 | -25,794 | -23,583 | -23,334.4934 | -18,507.5177 |
|
Normalized Income
|
-34,090.5516 | -26,229.4200 | -22,790.8400 | -22,266.4737 | -18,592.1960 |
|
Total Unusual Items
|
5,496.8764 | 3,202 | 4 | -2,173.2853 | 593.2782 |
|
Total Unusual Items Excluding Goodwill
|
5,496.8764 | 3,202 | 4 | -2,173.2853 | 593.2782 |
|
Tax Effect of Unusual Items
|
1,154.3440 | 672.4200 | 0.8400 | -456.3899 | 124.5884 |
|
Tax Rate, Calculated
|
0.21 | 0.21 | 0.21 | 0.21 | 0.21 |
12/31/2022 - 10/5/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade